Investigation of carbon emissions due to COVID-19 vaccine inventory

被引:0
|
作者
Nita H. Shah
Ekta Patel
Kavita Rabari
机构
[1] Gujarat University,Department of Mathematics
关键词
Vaccine inventory; Quality inspection; Carbon emissions; Carbon tax; Spoilage of vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
Inventory model for vaccine of COVID-19 pandemic is the subject of analysis in the proposed article. The initial registration for vaccination and vaccination of registered individuals is taken during the period under consideration. The paper considers the utility of vaccine during storage, holding cost, purchase cost, manufacturing cost and inspection cost. A fraction of registered individuals who do not turn up for a vaccination is taken into account. All the actions by the player incur carbon emissions. During the whole procedure of vaccination starting from raw material to end user carbon emissions are observed. Carbon emissions in stocking raw material, during inspection, during purchase activity, during set-up and transportation phase and holding it at point of delivery. Maximum carbon emission of 28% occur during purchase activity followed by 21% during transportation at the point of delivery and stocking it at respective places. To follow green policy, carbon tax is levied. A non-linear formulation of the proposed problem is modelled to compute optimum cycle time without allowing shortages. The convexity of the objective function is established through the numerical data. Analysis of carbon emissions and carbon tax levied is carried out through the data. Research Objective: Carbon Emission is one of a cause for ozone layer depletion. Moreover, it causes many ecological disturbances resulting into several environmental temperature variations. These all problem affect an individual’s health. So, there arise a need to frame a mathematical model to decipher relationship between COVID-19 vaccine inventory and effect of carbon emissions.
引用
收藏
页码:409 / 420
页数:11
相关论文
共 50 条
  • [41] The COVID-19 Vaccine Landscape
    Koch, Till
    Fathi, Anahita
    Addo, Marylyn M.
    CORONAVIRUS DISEASE - COVID-19, 2021, 1318 : 549 - 573
  • [42] COVID-19 vaccine safety
    Kostoff, Ronald N.
    Briggs, Michael B.
    Porter, Alan L.
    Spandidos, Demetrios A.
    Tsatsakis, Aristidis
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (05) : 1599 - 1602
  • [43] Vaccine against COVID-19
    Picazo, Juan J.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2021, 34 (06) : 569 - 598
  • [44] A new COVID-19 vaccine?
    Devi, Sharmila
    LANCET INFECTIOUS DISEASES, 2021, 21 (01): : 35 - 35
  • [45] Mucosal COVID-19 vaccine
    Devi, Sharmila
    LANCET INFECTIOUS DISEASES, 2022, 22 (06): : 776 - 776
  • [46] COVID-19 Vaccine and Myocarditis
    Salah, Husam M.
    Mehta, Jawahar L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 157 : 146 - 148
  • [48] COVID-19 Vaccine Hesitancy
    Storey, Doug
    GLOBAL HEALTH-SCIENCE AND PRACTICE, 2022, 10 (01):
  • [49] Covid-19 vaccine and breastfeeding
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2022, 61 (612): : 11 - 11
  • [50] COVID-19 vaccine hesitancy
    Eve Dubé
    Noni E. MacDonald
    Nature Reviews Nephrology, 2022, 18 : 409 - 410